Employees: 11-50
Investment Type: Venture Capital
Portfolio 72
| Date | Name | Website | Total Raised | Location |
| 04.11.2023 | ADARx Phar... | adarx.com | $321M | Canada |
| 05.06.2023 | ArriVent B... | arrivent.com | $415M | United Sta... |
| 26.08.2022 | Numab Ther... | numab.com | $149.9M | Switzerlan... |
| 26.08.2022 | C-Ray Ther... | c-raytherapeutics.com | - | - |
| 26.08.2022 | Mahzi | mahzi.com | - | Costa Rica |
| 26.08.2022 | Upstream B... | upstreambio.com | $400M | United Sta... |
| - | Arrakis Th... | arrakistx.com | $113M | United Sta... |
| - | Galera The... | galeratx.com | $260M | United Sta... |
| - | MicroOptx | microoptx.com | - | United Sta... |
| - | C4 Therape... | c4therapeutics.com | $243M | United Sta... |
Show more
Mentions in press and media 10
| Date | Title | Description |
| 28.05.2024 | Johnson & Johnson acquires Numab spin-off for USD 1.25 billion | Numab Therapeutics AG based in Horgen (ZH) is developing multi-specific antibody-based immunotherapies for inflammation and cancer. Johnson & Johnson will acquire global rights to Numabs lead molecule NM26, a Phase 2-ready investigatio... |
| 20.05.2021 | Numab Therapeutics Completes CHF 100 Million Series C Financing | |
| 20.05.2021 | Numab Therapeutics Completes CHF 100 Million Series C Financing | Numab Therapeutics aims to write the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. Its lead product was designed to balance potent anti-tumor immunity wit... |
| 02.10.2020 | Can Pharma-Biotech Alliances Solve The Innovation Crisis And Save The Industry? | Pharma cannot make enough new medicines to meet the needs of patients. (AP Photo/Elise Amendola)ASSOCIATED PRESS |
| 31.03.2015 | Applied Pharma Research Receives Minority Investment from HBM Partners | APR Applied Pharma Research s.a., a Balerna, Switzerland-based developer of science driven, patent protected Healthcare products, received a minority investment from HBM Partners. The amount of the deal was not disclosed. As part of it, Val... |
| 20.02.2013 | Gynesonics Completes $21M Series D | REDWOOD CITY, CA, Healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, announced a Series D financing led by HBM Partners based in Switzerland. >> Click here for more funding data on Gynesoni... |
| 20.02.2013 | Gynesonics Raises $21M Series D Funding | Gynesonics Inc., a Redwood City, California-based women’s healthcare company, raised a $21m Series D funding. The round was led by HBM Partners, with participation new investor Correlation Ventures and existing investors Abingworth, Advance... |
| 21.01.2013 | HBM investiert in Medtech Start-up Reha Technology | |
| 02.10.2012 | Percutaneous spinal implant maker Interventional Spine raises $1.6 million | Location: Irvine, California Solution/Product: The company makes several products for U.S. and overseas markets. Its most recent product is the FDA cleared PerX360° system that makes it possible to have a spinal fusion via two incisions tha... |
| - | Percutaneous spinal implant maker Interventional Spine raises $1.6 million | Interventional Spine, that has developed spinal implants that can be delivered percutaneously, raised $1.6 million by issuing debt. Here are the details: Industry: Medical devices Location: Irvine, California Solution/Product: The company m... |